Virtus Fund Advisers’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$411K Sell
10,407
-882
-8% -$33.5K ﹤0.01% 344
2017
Q3
$419K Sell
11,289
-703
-6% -$25K ﹤0.01% 303
2017
Q2
$454K Sell
11,992
-357
-3% -$13.1K ﹤0.01% 318
2017
Q1
$423K Sell
12,349
-6,544
-35% -$215K ﹤0.01% 340
2016
Q4
$623K Hold
18,893
0.01% 305
2016
Q3
$613K Sell
18,893
-4,676
-20% -$152K 0.01% 306
2016
Q2
$731K Hold
23,569
0.01% 296
2016
Q1
$710K Sell
23,569
-5,088
-18% -$140K 0.01% 307
2015
Q4
$799K Sell
28,657
-301
-1% -$8.56K 0.01% 302
2015
Q3
$889K Sell
28,958
-43,004
-60% -$1.5M 0.01% 290
2015
Q2
$2.64M Sell
71,962
-1,003
-1% -$35.8K 0.02% 286
2015
Q1
$2.58M Sell
72,965
-6,738
-8% -$231K 0.02% 295
2014
Q4
$2.44M Sell
79,703
-21,993
-22% -$686K 0.02% 308
2014
Q3
$2.98M Sell
101,696
-8,736
-8% -$266K 0.02% 294
2014
Q2
$3.15M Buy
+110,432
New +$3.08M 0.02% 314

Other funds holding EHC

Virtus Fund Advisers's EHC Position: Q4 2017 in Review

Virtus Fund Advisers reduced its Encompass Health (EHC) stake by 7.8% in Q4 2017, selling an estimated $33.5K and leaving 10,407 shares worth $411K. The position accounts for ﹤0.01% of the portfolio, ranked #344.

Virtus Fund Advisers first reported a position in EHC in Q2 2014 and has held it in 15 quarters since. The position peaked at $3.15M in Q2 2014. 300 funds tracked by Wall St. Rank hold EHC as of Q4 2017.

  • Virtus Fund Advisers held 10,407 shares of Encompass Health worth $411K as of Q4 2017.
  • Virtus Fund Advisers sold 882 Encompass Health shares in Q4 2017, an estimated $33.5K.
  • Encompass Health made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #344 holding.
  • Virtus Fund Advisers first reported a position in Encompass Health in Q2 2014 and has held it in 15 quarters since.
  • Virtus Fund Advisers's Encompass Health position peaked at $3.15M in Q2 2014.
  • 300 funds tracked by Wall St. Rank held Encompass Health as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.